Lawrence Keusch analyst

Currently out of the existing stock ratings of Lawrence Keusch, 106 are a BUY (91.38%), 10 are a HOLD (8.62%).

Lawrence Keusch

Work Performance Price Targets & Ratings Chart

Analyst Lawrence Keusch, carries an average stock price target met ratio of 73.69% that have a potential upside of 20.13% achieved within 261 days. Previously, Lawrence Keusch worked at WELLS FARGO, RAYMOND JAMES.

Lawrence Keusch’s has documented 226 price targets and ratings displayed on 13 stocks. The coverage was on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on BDX, Becton Dickinson and Company at 02-May-2025.

Wall Street Analyst Lawrence Keusch

Analyst best performing recommendations are on AVTR (AVANTOR).
The best stock recommendation documented was for HAE (HAEMONETICS) at 8/5/2020. The price target of $93 was fulfilled within 35 days with a profit of $16.89 (22.19%) receiving and performance score of 6.34.

Average potential price target upside

AVNS Avanos Medical AVTR Avantor BAX Baxter International BDX Becton Dickinson and Company COO The Cooper Companies Common Stock HAE Haemonetics HRC Hill-Rom Holdings ISRG Intuitive Surgical MASI Masimo SYK Stryker TFX Teleflex ZBH Zimmer Biomet Holdings CMD Cantel Medical Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 01-Apr-2020

$14

$-10.95 (-43.89%)

$17

1 years 4 months 27 days ago
(07-May-2025)

11/11 (100%)

$1.42 (11.29%)

168

Buy Since 06-Apr-2018

$34

3 years 2 months 10 days ago
(25-Jul-2023)

6/14 (42.86%)

$11.59 (51.72%)

153

Buy Since 22-May-2023

$31

$6.01 (24.05%)

$30

3 years 4 months 13 days ago
(22-May-2023)

5/6 (83.33%)

$7.45 (31.63%)

437

Sell Since 04-Aug-2021

$26

$1.01 (4.04%)

$28

3 years 5 months 1 days ago
(04-May-2023)

5/8 (62.5%)

$2.46 (10.45%)

44

Hold Since 04-Aug-2021

$40

$15.01 (60.06%)

$45

4 years 11 months 2 days ago
(03-Nov-2021)

3/5 (60%)

$3.98 (11.05%)

100

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?